Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia

Published:2020-08 Issue:8 Volume:26 Page:1425-1432
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Mei Matthew,Tsai Ni-Chun,Mokhtari Sally,Al Malki Monzr M.,Ali Haris,Salhotra Amandeep,Sandhu Karamjeet,Khaled Samer,Smith Eileen,Snyder David,Marcucci Guido,Forman Stephen J.,Pullarkat Vinod,Stein Anthony,Aldoss Ibrahim,Nakamura Ryotaro

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference38 articles.

1. Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Hoelzer;Ann. Oncol,2016

2. Catalyzing improvements in ALL therapy with asparaginase;Marini;Blood Rev,2017

3. Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial;Patel;Leukemia,2017

4. A population-based cytogenetic study of adults with acute lymphoblastic leukemia;Moorman;Blood,2010

5. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis;Stengel;Blood,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age barriers in allogeneic hematopoietic cell transplantation: Raising the silver curtain;American Journal of Hematology;2024-02-27

2. Leveraging CD19CAR T cells early in the treatment of older patients with B-ALL: are we there yet?;Leukemia & Lymphoma;2024-01-05

3. Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies;Hematology;2023-12-08

4. In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial;The Lancet Haematology;2022-04

5. Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity;Blood Advances;2022-03-11